Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2016-05-02

Clinical Trial Update: Symptomatic Treatment of Vascular Cognitive Impairment [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update describing a Phase 2/Phase 3 study of symptomatic treatment for vascular cognitive impairment, with current status unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Amsterdam UMC, location VUmc | Conditions: Mild Cognitive Impairment (Vascular), Mild Cognitive Disorder (Vascular) | Phase 2, Phase 3 | Status: UNKNOWN